Assessing the Impact of Technological Advancements on Vascular Stents Market Growth

 


What are Vascular Stents?

Vascular stents are medical devices that are used to treat narrow or blocked blood vessels. They are small, mesh-like tubes that are inserted into the affected artery to help prop it open and improve blood flow. The global vascular stents market is expected to grow significantly in the coming years due to an increase in the prevalence of cardiovascular diseases, technological advancements in stent design, and the growing aging population.

Vascular Stents Market Size and Forecast

The global vascular stents market size is expected to reach USD 16.52 billion by 2028, growing at a CAGR of 6.7% from 2021 to 2028. North America dominates the market due to a high prevalence of cardiovascular diseases, increased healthcare spending, and better healthcare infrastructure.

Vascular Stents Market Trends and Analysis

The market is experiencing a shift towards the development of bioresorbable stents that dissolve within the body after the artery has healed. This reduces the risk of complications associated with permanent stents, such as restenosis and thrombosis.

Key Companies in the Vascular Stents Market

The key companies operating in the vascular stents market include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical Inc., Medtronic plc, and Terumo Corporation. These companies are focused on developing innovative products to gain a competitive advantage and expand their market share.

Pipeline Therapies in the Vascular Stents Market

The vascular stents market is experiencing significant growth due to the development of new pipeline therapies. For instance, Bioabsorbable Magnesium Alloy Stent (BIOMAG), a bioresorbable stent, is being developed by REVA Medical, Inc. for the treatment of coronary artery disease.

Market Drivers for the Vascular Stents Market

Out of many other market drivers for vascular stents, the market is being driven by the increasing prevalence of cardiovascular diseases, rising demand for minimally invasive surgeries, and technological advancements in stent design.

Market Barriers for the Vascular Stents Market

The market is facing several challenges, the market barriers for Vascular Stents market includes the high cost of stent procedures, stringent regulatory policies, and a lack of skilled healthcare professionals.

Upcoming Trends in the Vascular Stents Market

The market is expected to witness an increase in the adoption of drug-eluting stents and a shift towards the development of bioresorbable stents. Moreover, there is an increasing focus on the development of stents with improved biocompatibility and reduced thrombogenicity.

Conclusion

The global vascular stents market is expected to grow significantly in the coming years due to the increasing prevalence of cardiovascular diseases and the growing aging population. The market is experiencing a shift towards the development of bioresorbable stents, and vascular stents key players are focused on developing innovative products to gain a competitive advantage. However, the market is facing several challenges, including the high cost of stent procedures and stringent regulatory policies. Despite these challenges, the vascular stents market is poised for significant growth in the coming years.


To know more about our Consulting Services, Click here: DelveInsight Healthcare Consulting


Related Reports by DelveInsight- 

scedosporium infection market | autoimmune pulmonary alveolar proteinosis market | rosai-dorfman disease market | sandhoff disease market | b-cell chronic lymphocytic leukemia market | bladder cancer market | trichomoniasis market | bile duct cancer market | resorbable vascular scaffold market | salivary gland infection market | ischemic stroke market | paget's disease market | ventricular assist devices market | vascular stents market | vascular graft devices market | bladder scanners market | b-cell non-hodgkin lymphoma market | basal cell carcinoma market | birch allergy market | vein illumination devices market


Recent Blog’s By DelveInsight:

Comments

Post a Comment

Popular posts from this blog

The Science Behind Vaccine Adjuvants: Strengthening Our Defenses

Image
  What are Vaccine Adjuvants? Vaccine adjuvants are substances added to vaccines to enhance the body’s immune response to the provided antigen. By boosting the efficacy of vaccines, adjuvants play a crucial role in providing long-lasting immunity against infectious diseases. They can help reduce the amount of antigen needed, thereby improving vaccine stability and cost-effectiveness. Types of Vaccine Adjuvants There are several types of vaccine adjuvants , each working through different mechanisms. Traditional adjuvants include aluminum salts (alum), which have been used for decades. Modern adjuvants include oil-in-water emulsions, liposomes, and saponins. Recent advancements have introduced TLR (Toll-like receptor) agonists, which stimulate specific immune pathways to enhance the vaccine's effectiveness. These include TLR3, TLR4, and TLR9 agonists, which mimic natural infection signals to elicit a stronger immune response. Vaccine Adjuvants Market Dynamics The global vaccine adju
Read more

FDA Approval Marks New Hope: Eli Lilly’s Donanemab for Alzheimer’s Disease

Image
  The Birth of a Breakthrough Eli Lilly’s groundbreaking drug, Donanemab, has recently received FDA approval, marking a significant milestone in Alzheimer’s disease treatment . This innovative therapy, designed to target and reduce amyloid plaques in the brain, offers new hope for patients battling this debilitating condition. Donanemab’s approval comes at a pivotal moment, as it represents a major advancement in the Alzheimer’s disease pipeline, promising improved outcomes for those affected. Navigating Regulatory Waters The journey of Donanemab through the regulatory landscape was complex, characterized by rigorous scrutiny and extensive clinical trials. Eli Lilly’s success in obtaining FDA approval highlights the drug’s potential to revolutionize Alzheimer’s disease therapies . This regulatory endorsement not only underscores the efficacy and safety of Donanemab but also sets a new standard for the evaluation of future treatments. Donanemab: Cost and Coverage As with many groundbre
Read more

Papilloma Market Report: Detailed Epidemiology and 2032 Forecast

Image
Papilloma is a benign tumor that arises from epithelial tissue and is often associated with the human papillomavirus (HPV). These tumors can occur in various body parts, including the skin, mucous membranes, and genital areas. Understanding the market dynamics, epidemiology, and future trends for papilloma is crucial for developing effective treatments and improving patient outcomes. Papilloma Market Insight The papilloma market is experiencing steady growth, driven by increasing awareness of HPV-related diseases and advancements in diagnostic technologies. Papilloma can lead to complications if left untreated, making early diagnosis and effective treatment essential. The market for papilloma therapies includes a range of options such as antiviral drugs, cryotherapy, and surgical interventions. The introduction of novel therapies and ongoing research into targeted treatments are expected to enhance patient outcomes and drive market growth. Papilloma Epidemiology Papilloma is relative
Read more